ArticleScientific reports2026
Parasite population dynamics shaped P. falciparum pfhrp2 and pfhrp3 deletion expansion in the Peruvian Amazon.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Malaria control and the unexpected spread of diagnostic-resistantbioRxiv : the preprint server for biology · 2026Article
- Local variability inMalariaWorld journal · 2026Article
Corrections and comments
- Update of
Authors and funding
7 authors.
Funding
Abstract
Plasmodium falciparum populations in the Peruvian Amazon have undergone changes in the last 20 years, coinciding with the implementation of the PAMAFRO malaria control program (2005-2011). In this context, parasites with deletions of the pfhrp2 and pfhrp3 (pfhrp2/3) genes, involved in rapid diagnostic test (RDT) failure, have been increasingly predominant in Peru since 2012. Here, we investigated population genomic processes shaping P. falciparum populations in the Peruvian Amazon, using the PAMAFRO program as a reference point. We analyzed the genomic changes over 102 isolates between 2006 and 2018, grouped in two periods: 33 samples from 2006 to 2011 (Period 1, before PAMAFRO) and 69 from 2012 to 2018 (Period 2, after PAMAFRO). We found a reduction in the parasite population structure complexity, a significant decrease in genetic diversity and a clonal population structure in Period 2. The pfhrp2/3 deletion profiles differed significantly between periods, with the double pfhrp2/3 deletion being predominant in only Period 2 (68%). Importantly, no evidence of positive selection was found on the pfhrp2/3 loci. Together, these results indicate that P. falciparum populations in Peru experienced a bottleneck associated with PAMAFRO, followed by the clonal expansion of the parasites carrying pfhrp2/3 deletions. In contrast to the Horn of Africa, the deletion of the pfhrp2/3 genes were not selected in Peru, and their expansion is better explained by a different evolutionary process, such as genetic drift. These results highlight the importance of population genomic analysis in uncovering the patterns shaping the parasite population in Peru, which impacts malaria diagnostics and other control strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.